Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
Farnaz Amoozegar, Tamara PringsheimCalgary Headache Assessment and Management Program, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, CanadaAbstract: Rizatriptan is a 5HT (IB/ID) agonist with proven efficacy in the acute treatment of migraine headache. We performed a syste...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-08-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/rizatriptan-for-the-acute-treatment-of-migraine-consistency-preference-a3443 |